1-3 of 3
Hilde Giezek
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effect of Pembrolizumab Monotherapy Versus Brentuximab Vedotin (BV) on Symptoms Associated with Health-Related Quality of Life (HRQoL) in Relapsed/Refractory (R/R) Classical Hodgkin Lymphoma (cHL) in the Randomized, Phase 3, Keynote-204 Study

Pier Luigi Zinzani, MD, Radhakrishnan Ramchandren, Armando Santoro, Ewa Paszkiewicz-Kozik, Robin Gasiorowski, Nathalie A Johnson, MD PhD, José S. R. de Oliveira, Valeria Buccheri, Guilherme Fleury Perini, Michael Dickinson, DMed Sci, Andrew McDonald, Muhit Ozcan, Naohiro Sekiguchi, Monika Raut, Hilde Giezek, Akash Nahar, John Kuruvilla, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–20.
https://doi.org/10.1182/blood-2020-139416
Published: 2020
Journal Articles

Clinical Outcomes of Patients with 3 rd or Higher Relapsed Classical Hodgkin Lymphoma: Results from the German Hodgkin Study Group

Paul Broeckelmann, Horst Mueller, PhD, Esra Kücüksarioglan, Peter Kaskel, MD MBA, Veronika Metterlein, MPH, Hilde Giezek, MSc Biostatistics, Arun Balakumaran, MD PhD, Monika Raut, PhD MS, Andreas Engert, MD, Bastian von Tresckow
Journal: Blood
Blood (2017) 130 (Supplement 1): 2793.
https://doi.org/10.1182/blood.V130.Suppl_1.2793.2793
Published: 2017
Journal Articles

Patient-Reported Outcomes in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab Monotherapy, Results of a Phase 2 Study

Bastian von Tresckow, Michelle A. Fanale, MD, Kirit M Ardeshna, MA MDFRCP FRCPath, Robert W. Chen, MD, Julia Meissner, MD, Franck Morschhauser, MD PhD, Craig H. Moskowitz, MD, Pier Luigi Zinzani, MD, Hilde Giezek, Arun Balakumaran, MD PhD, Monika Raut, PhD MS, Thao Vo, Pauline Brice, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2169.
https://doi.org/10.1182/blood.V130.Suppl_1.2169.2169
Published: 2017